Últimas Noticias del Cáncer

FDA Approves Nivolumab and Ipilimumab Combination for Advanced Kidney Cancer (02-18-2019)
The Food and Drug Administration (FDA) approved the immunotherapy drugs Opdivo and Yervoy in combination as an initial, or first-line, treatment for patients with advanced kidney cancer whose disease has... Continue Reading

Keytruda Plus Inlyta Improves Survival Compared ot Sutent for Treatment of Advanced Kidney Cancer (02-18-2019)
Results from the randomized, phase III KEYNOTE-426 clinical trial show that first-line therapy with a combination of the PD-1 targeted immunotherapy Keytruda (pembrolizumab) and the VEGF-targeted tyrosine... Continue Reading

Adjuvant Taxotere Doesn’t Improve Outcomes in Early Stage High Risk Prostate Cancer (02-11-2019)
Patients with high-risk, non-metastatic prostate cancer saw no survival advantage and no delay in metastases with the addition of adjuvant docetaxel to androgen deprivation therapy (ADT), according to... Continue Reading

More Cancer News

Ubicaciones

MONTEREY
5 Harris Court, Edificio T, Suite 201
Monterey, CA 93940
(Teléfono) 831-375-4105 (fax) 831-372-5722
Haz clic aquí para ver el mapa

 
 
 
 

MORGAN HILL
18525 Sutter Boulevard, Suite 170
Morgan Hill, CA 95037
(Teléfono) 408-779-9843 (fax)408-779-9874
Haz clic aquí para ver el mapa